I would sarcastically say that with all the testing done on the vaccines, what worry would there be?
But it seems experimentation is still ongoing.
But it seems experimentation is still ongoing.
Quote:Study to see if Covid vaccine is safe for pregnant women launches at RVI in NewcastleChronicle Live:
The research, the first one in the UK, aims to understand the safety of the Pfizer-BioNTech jab
in healthy pregnant women - volunteers will be able to join the study in Newcastle
'The first UK study to see if the Covid vaccine is safe for pregnant women is launching at a Newcastle hospital.
The research aims to further understand the safety and tolerability of the Pfizer-BioNTech Covid-19 vaccine in
healthy pregnant women.
The study will be carried out across 11 National Institute for Health Research sites, including the Royal Victoria
Infirmary in Newcastle, and around 235 volunteers will be involved across the UK.
Pregnant women are now offered approved vaccines at the same time as the rest of the UK population, based
on their age and clinical risk group. Data from the United States has been collected, in which over 100,000 pregnant
women have been vaccinated (mainly with mRNA vaccines including Pfizer-BioNTech), without any safety concerns
raised.
The role of this placebo controlled study is to provide more robust information on the vaccine immune response in
pregnancy, as well as safety reporting and the potential transfer of maternal antibodies to babies. Each participant
enrolled in the study will initially receive either two doses of the vaccine or a placebo 21 days apart.
Recruitment will begin this week at the UK sites involved. The research has already been running in the US since
February.
Mums-to-be will be required to answer questionnaires about their health, provide blood samples, complete an e-diary
and will receive extra monitoring while on the study, compared to those who receive a vaccine through the rollout.
The North East volunteers will need to go the RVI for four planned visits before their baby is born and then two more
follow up appointments after the birth. Participants will be identified via obstetricians and midwives at the hospital,
with the study doctor determining whether each pregnant woman and their unborn baby would be suitable.
Taking part is voluntary and people can leave the study at any time.
Dr Chrissie Jones, associate professor in paediatric infectious diseases at University of Southampton, and chief
investigator for the study, said: "While we have a large amount of real-world data which tells us that it's safe for
pregnant women to receive approved Covid-19 vaccines, the data gathered from a controlled research study like
this is important because it will give us more information about the vaccine immune response in pregnant women,
including the transfer of maternal antibodies to infants.
"All women taking part in the study will receive two doses of the approved Pfizer-BioNTech vaccine, as well as
additional monitoring and support from their local research team." Dr Ken Hodson, principal investigator of the
study at the RVI in Newcastle, added: "This study will help us to better understand both the safety and immunogenicity
of the Pfizer-BioNTech vaccine for pregnant women and infants...'
Edith Head Gives Good Wardrobe.